Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
CANCTema

Tema Oncology ETF

$40.26-1.95% vs prior close
344552-WK

Price through Nov 16, 2026 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.

The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.

CANC price

Source: Market tape, daily closes; price return, distributions not reinvested
Table
DateCANC close
Oct 16, 2026$39.65
Oct 19, 2026$40.01
Oct 20, 2026$41.59
Oct 21, 2026$41.53
Oct 22, 2026$41.50
Oct 23, 2026$41.29
Oct 26, 2026$40.99
Oct 27, 2026$41.75
Oct 28, 2026$42.60
Oct 29, 2026$42.35
Oct 30, 2026$42.29
Nov 2, 2026$41.67
Nov 3, 2026$42.10
Nov 4, 2026$42.89
Nov 5, 2026$40.78
Nov 6, 2026$41.85
Nov 9, 2026$43.37
Nov 10, 2026$42.68
Nov 11, 2026$42.29
Nov 12, 2026$41.21
Nov 13, 2026$41.06
Nov 16, 2026$40.26

The desk’s read

Recent fund-flow records are unavailable, while the price has returned +16.0% so far this year. At 0.99% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$51Massets under management
0.99%expense ratio · $99 per $10,000 a year
—net flow, trailing month
19Kavg daily volume, 30 days
56holdings · US-domiciled
2023listed August 14, 2023 · beta 0.80
The book at a glance
GMAB+0.4%LLY-0.8%RVMD-3.1%MRK-2.2%ONC-1.3%COGT-3.9%ABBV-0.2%EXEL-2.8%CGON+14.0%BBIO-1.2%HALO-3.8%BMY-0.8%ELVN-2.4%JNJ-1.1%IDYA-4.6%RLAY-4.5%IMNM-6.2%AMGN-0.7%ERAS-3.5%ZLAB-4.6%IOVA-2.7%LEGN-8.6%ZYME+0.8%CELC-5.9%SMMT-16.5%REPL-2.2%GILD-0.3%GH-5.1%NUVB-3.8%CRVS-0.4%RCUS-3.3%URGNKURAIMCR

CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS

Holdings
#HoldingWeightPriceDay52-wk
1GMABGENMAB A5.82%$51.57+0.4%
2LLYELI LILLY5.62%$1431.67-0.8%
3RVMDREVOLUTION MEDICINES5.34%$166.87-3.1%
4MRKMERCK & CO5.03%$144.46-2.2%
5ONCBeiGene4.34%$411.29-1.3%
6COGTCOGENT BIOSCIENCES4.31%$27.44-3.9%
7ABBVABBVIE3.88%$294.55-0.2%
8EXELEXELIXIS3.74%$67.10-2.8%
9CGONCG ONCOLOGY INC2.89%$84.78+14.0%
10BBIOBRIDGEBIO PHARMA3.20%$77.36-1.2%
11HALOHALOZYME THERAPEUTICS3.02%$96.50-3.8%
12BMYBRISTOL MYERS SQUIBB2.79%$62.93-0.8%
13ELVNENLIVEN THERAPEUTICS2.76%$47.62-2.4%
14JNJJOHNSON & JOHNSON2.41%$282.55-1.1%
15IDYAIDEAYA BIOSCIENCES2.27%$30.36-4.6%

The full book, free with one sign-in.

Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.

Sign in to see all 56

Sector weights

  • Healthcare100%
  • Health Technology88.87%
  • Health Services8.46%
  • Other4.09%
  • Technology Services1.59%
  • Mutual fund1.06%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
Healthcare100%
Health Technology88.87%
Health Services8.46%
Other4.09%
Technology Services1.59%
Mutual fund1.06%

Country weights

  • United States82.49%
  • Switzerland7.31%
  • Japan6.83%
  • Denmark5.94%
  • United Kingdom2.34%
  • China1.92%
  • Germany1.5%
  • Netherlands1.37%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
United States82.49%
Switzerland7.31%
Japan6.83%
Denmark5.94%
United Kingdom2.34%
China1.92%
Germany1.5%
Netherlands1.37%
Performance
1 week-5.7%
1 month+1.5%
3 months-5.6%
6 months+8.6%
YTD+16.0%
1 year—
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week—
1 month—
3 months—
YTD—
1 year—

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

The risk read
34%realized volatility, 30 days (annualized)
24%realized volatility, 1 year
-13.2%deepest fall from a peak, 1 year
-11.0%latest close versus that peak

The top holding is 5.8% of the book; the top ten carry 45%. Spread across 56+ names, it behaves like roughly 32 equally-weighted positions.

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.